Suchergebnisse - "LAI Shujie"

PubPharm (7)

1

A Nomogram for Predicting Portal Hypertensive Gastropathy in Patients With Liver Cirrhosis : A Retrospective Analysis

enthalten in: Frontiers in medicine | 2022

von Wang, W. | Mu, Z. | Zhu, G. | +6

2

Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Acts as Diagnostic Biomarker and Adverse Prognostic Factor of Hepatocellular Carcinoma (HCC) : Evidence from Bioinformatic Analysis

enthalten in: Medical science monitor : international medical journal of experimental and clinical research | 2020

von Wang, W. | Zhu, G. | Lai, S. | +4

3

Liver injury in coronavirus disease 2019

in: Linchuang Gandanbing Zazhi | 2020

von LAI Shujie

4

PKCδ silencing alleviates saturated fatty acid induced ER stress by enhancing SERCA activity

enthalten in: Bioscience reports | 2017

von Lai, S. | Li, Y. | Kuang, Y. | +7

5

Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease : A meta-analysis study

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2016

von Sun, W. | Cui, H. | Li, N. | +5

6

Comparison of FIB‐4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non‐alcoholic fatty liver disease: A meta‐analysis study

enthalten in: Hepatology research | 2016

von Sun, W. | Cui, H. | Li, N. | +5

7

Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer : a meta-analysis of randomized controlled trials

enthalten in: Medicine | 2014

von Xiong, J. | Lai, S. | Zhang, P. | +7

RetractionIn: Medicine (Baltimore). 2014 Dec;93(29):399. - PMID 25546656

1
[1]